|
|
 |
BENZALKONIUM CHLORIDE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
INVOKAMET XR Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
INOMAX Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ALBUMIN HUMAN Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ISOPROPYL ALCOHOL Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ISOPROPYL MYRISTATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ASPARTAME Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$798.00 |
|
|